GSK Rises After Settling Zantac Cases for Up to $2.2 Billion
GSK Plc shares surged after the UK pharma company agreed to pay as much as $2.2 billion to resolve about 80,000 US court ...
WJET Erie on MSN5d
Drugmaker to settle nearly 80,000 Zantac lawsuits for up to $2.2 billion
UK-based pharmaceutical giant GSK, or GlaxoSmithKline, has announced that it has agreed to settle nearly 80,000 state-level ...
GSK jumps 6% after $2.2B Zantac settlement: why analysts see more upside
GlaxoSmithKline (GSK) saw its shares jump more than 6% after the pharmaceutical giant announced a settlement of up to $2.2 ...
GSK to pay $2.2bn to settle Zantac lawsuits
GSK has agreed to pay $2.2bn to settle about 80,000 Zantac lawsuits in the US. In a statement released after the close of ...
Morningstar6d
GSK settles vast majority of Zantac claims for $2.2 billion
noted the 7% of plaintiffs who are yet to settle with GSK could still cause problems for the British firm. GSK's settlement saw it reach an agreement with the 10 largest law firms handling Zantac ...
pharmaphorum1y
GSK settles first jury trial in Zantac litigation
GSK has opted to settle a key lawsuit in its defence against claims that its Zantac drug caused cancer ... Nevertheless, the drug was pulled off the market in 2020. There had been speculation ...
GSK: The Worst Is Finally Over (Rating Upgrade)
GSK's share price rose 6% after settling 93% of Zantac cases, impacting Q3 earnings; forward non-GAAP P/E remains reasonable ...
San Gabriel Valley Tribune6d
GSK to settle 80,000 Zantac cases for up to $2.2 billion
The US Food and Drug Administration asked companies producing Zantac to remove all ranitidine-based drugs from the US market in 2020 ... as other drugmakers are still facing trials, including ...